Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENERGIA: Exercise in Rare Hematologic Diseases With Individualized and Adapted Management

NCT07518940 is registered in ClinicalTrials.gov with Carmen Fava as lead sponsor.

NCT NCT07518940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07518940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENERGIA: Exercise in Rare Hematologic Diseases With Individualized and Adapted Management
Lead sponsor
Carmen Fava
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
December 31, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia (cml), myelofibrosis, primary, myeloproliferative disease, polycythemia vera, thrombocythemia essential